Lumpectomy Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 – 2034
Report ID: GMI4189
Download Free PDF
Authors:
Monali Tayade,
Lumpectomy Market Size
The global lumpectomy market generated considerable revenues in 2024 and is projected to grow at a decent CAGR between 2025 and 2034, due to rising breast cancer incidences and a preference for breast-conserving surgeries. As per American Cancer Society there were about 310,720 new cases of invasive breast cancer and 56,500 cases of ductal carcinoma in situ (DCIS) diagnosed among U.S. women in 2024 and 42,250 women died from breast cancer.
Market growth has been significantly contributed by increased emphasis on early detection of breast cancers, improved imaging technologies, and enhanced surgical outcomes. Lumpectomy, or breast-conserving surgery or wide local excision, enables the removal of malignant tissue while conserving breast tissue, resulting in both physical and psychological benefits over mastectomy.
The increasing global burden of breast cancer, which is still one of the most frequently diagnosed cancers in women, has contributed to the growth of lumpectomy procedures. Increased screening initiatives and advancements in diagnosis accuracy led to increased diagnoses of early-stage cancers allowing for more patients to undergo breast-conserving lumpectomy surgery versus an invasive procedure. Overall, surgical improvements, such as precision-guided lumpectomy devices and margin evaluation systems, have improved procedural success rates and decreased re-excision requirements. Despite this positive growth towards breast-conserving lumpectomy, the market still faces certain limitations, including procedure costs.
Lumpectomy Market Trends
Various trends are impacting the future of the lumpectomy market. One key trend is a shift toward minimally invasive and image-guided procedures. Newer technologies such as intraoperative imaging, optical coherence tomography, and margin mapping have changed the way lumpectomies are performed, allowing for tumors to be removed with precision while maintaining a healthy margin and sandwiching in-situ cancers. Another trend, which is somewhat more proactive, is the application of AI and machine learning algorithms to assist with preoperative planning, real-time surgical decision-making, and postoperative monitoring. These advances are resulting in fewer re-excisions, better surgical margins, and ultimately better long-term patient outcomes.
Wireless localization systems are also being embraced, giving patients an appealing option instead of conventional wire-guided localization. These systems not only help improve the efficiency or workflow of surgery but also allow for scheduling flexibility in the busy world of hospitals and outpatient procedures. New developments in the concept of personalized oncology are also coming into play, as tumor profiling and genomic tests help to determine the extent of surgery and any adjuvant therapy considerations. The push towards patient-centered care (with an emphasis on quality of life) and improved cosmetic outcomes is shaping decisions made by the surgical oncology team, favoring lumpectomy over other more radical approaches.
Lastly, the healthcare world is now more complex than ever, with various stakeholders approaching decisions from different perspectives (cost vs efficiency vs satisfaction). The information presented suggests that the lumpectomy market is changing, simply because of the new tools and the educational benefits of new technologies.
Lumpectomy Market Analysis
The lumpectomy systems segment held the largest share in 2024 driven by the surgical tools or devices used to excise tumors and assess margins intraoperatively. Products in this segment include Radiofrequency Guided Localization Systems, scalpel-based excision instruments, electrosurgical devices, and tissue marking systems. This segment captured the largest revenue in 2023, because of its importance in improving quality, avoiding cancer recurrence, and accuracy. Companies have begun to create innovative lumpectomy systems, with the latest capabilities being advanced imaging-guided systems to provide the surgeon with real-time tumor margin visualization.
Minimally invasive lumpectomy systems are commonly utilized when patients undergo outpatient, as well as when patients belong to a hospital. There are several systems promoting wireless localization, in place of wire-guided localization, which can cause discomfort, logistical delays, or scheduling issues with the wire-guided localization. Collectively, these new systems are creating better logical processes, increasing the efficiency of procedures, improving accuracy, and aligning with more productive surgical environments for workflow processes.
The lumpectomy market from ambulatory surgical centers (ASC) segment generated notable revenues in 2024. The healthcare industry is embracing outpatient procedures that are cost-effective, efficient, and minimally aimed toward invasive treatment. There are benefits of ASCs specifically for outpatient lumpectomy procedures because they are typically short, they have a lower rate of complications, and they have a lower rate of post-operative recovery time. Patients appreciate ASCs considering their convenience, shorter hospitalizations, and the less overall expense compared to procedures conducted in traditional hospitals.
Alongside traditional outpatient models, increased development of anesthesia techniques, pain management techniques, and same-day discharge where lumpectomy can be incorporated into an ambulatory procedure have empowered ASCs to develop and utilize operational efficiencies. For the ASC, renewed interest and increased utilization of ASCs position them favorably with streamlined operations, accelerated procedure, scheduling, and overhead fees to provide a lower cost and expand services to a wider range of patients. There will be continued demand for lumpectomy services offered in ASCs with the increasing incidence of early-stage breast cancer and early detection. The market demand will trend upwards, particularly in urban areas with advantageous healthcare access.
North America lumpectomy market will continue to hold robust position during 2025-2034 driven by the high breast cancer incidence rate, high levels of adoption of surgical technologies, and a strong healthcare infrastructure. The US is the largest contributor, followed by some distance by Canada. The US also leads in new awareness campaigns, government-assisted screening, access to innovative treatment paradigms, and robust public funding for breast cancer in leading-edge treatment. There is a higher growing demand for breast-conserving surgery than mastectomy, given patient preference for better cosmetic outcomes.
The presence of major medical device companies that focus on designing and commercializing lumpectomy systems also contributes to regional growth. In addition, reimbursement policy has significantly contributed to an increase in health insurance payment levels, improved accessibility to alternative procedures (with skilled surgical professionals), and recent model outpatient surgery and value-based care models now allow ambulatory surgical centers to be advanced, thereby removing limits to access.
Lumpectomy Market Share
Key players in the lumpectomy industry include:
To solidify their existing market position, the leading companies operating in the lumpectomy market are focusing on product innovation, strategic partnerships, and geographic growth. They are focusing on developing advanced imaging-guided surgical systems, wireless localization, and AI-augmented margin assessment technologies to promote surgical precision and enhance patient outcomes. Allied partnerships with hospitals and ambulatory surgical centers are helping to expand their reach and promote the acceptance of new devices. In emerging markets, companies continue to create more affordable solutions and invest in local manufacturing. In addition, many companies pursue direct acquisitions or mergers to bring complementary technologies and broaden their product portfolio and scope.
Lumpectomy Industry News
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →